All Stories

  1. N-Terminomic Changes in Neurons During Excitotoxicity Reveal Proteolytic Events Associated With Synaptic Dysfunctions and Potential Targets for Neuroprotection
  2. CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation
  3. Src family kinases and their role in hematological malignancies
  4. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
  5. Dual role of Src kinase in governing neuronal survival
  6. Global Analysis of Human Nonreceptor Tyrosine Kinase Specificity Using High-Density Peptide Microarrays
  7. Activation of Src family tyrosine kinases by ferric ions
  8. Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2)
  9. A Truncated Fragment of Src Protein Kinase Generated by Calpain-mediated Cleavage Is a Mediator of Neuronal Death in Excitotoxicity
  10. Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations
  11. Aberrant regulation and function of Src family tyrosine kinases: Their potential contributions to glutamate‐induced neurotoxicity
  12. Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1)
  13. Defining the Substrate Specificity Determinants Recognized by the Active Site of C-Terminal Src Kinase-Homologous Kinase (CHK) and Identification of β-Synuclein as a Potential CHK Physiological Substrate
  14. Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide
  15. A facile, click chemistry-based approach to assembling fluorescent chemosensors for protein tyrosine kinases
  16. Development of the procedures for high-yield expression and rapid purification of active recombinant Csk-homologous kinase (CHK): Comparison of the catalytic activities of CHK and CSK
  17. Unique biochemical properties of the protein tyrosine phosphatase activity of PTEN—Demonstration of different active site structural requirements for phosphopeptide and phospholipid phosphatase activities of PTEN
  18. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases
  19. Allosteric networks governing regulation and catalysis of Src‐family protein tyrosine kinases: Implications for disease‐associated kinases
  20. Biochemical aspects of the neuroprotective mechanism of PTEN‐induced kinase‐1 (PINK1)
  21. Identification of functional domains in Arabidopsis thaliana mRNA decapping enzyme (AtDcp2)
  22. Decreased CHK protein levels are associated with Src activation in colon cancer cells
  23. Expression, generation, and purification of unphosphorylated and phospho-Ser-380/Thr-382/Thr-383 form of recombinant PTEN phosphatase
  24. PTEN catalysis of phospholipid dephosphorylation reaction follows a two-step mechanism in which the conserved aspartate-92 does not function as the general acid — Mechanistic analysis of a familial Cowden disease-associated PTEN mutation
  25. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1
  26. C-terminal Src Kinase-homologous Kinase (CHK), a Unique Inhibitor Inactivating Multiple Active Conformations of Src Family Tyrosine Kinases
  27. PTEN is recruited to specific microdomains of the plasma membrane during lactacystin-induced neuronal apoptosis
  28. Csk homologous kinase
  29. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)—endogenous negative regulators of Src-family protein kinases
  30. Lactacystin-induced apoptosis of cultured mouse cortical neurons is associated with accumulation of PTEN in the detergent-resistant membrane fraction
  31. A Novel Non-catalytic Mechanism Employed by the C-terminal Src-homologous Kinase to Inhibit Src-family Kinase Activity
  32. Modulation of the Catalytic Activity of the Src Family Tyrosine Kinase Hck by Autophosphorylation at a Novel Site in the Unique Domain
  33. Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530
  34. Common in Vitro Substrate Specificity and Differential Src Homology 2 Domain Accessibility Displayed by Two Members of the Src Family of Protein-tyrosine Kinases, c-Src and Hck
  35. Common and differential recognition of structural features in synthetic peptides by the catalytic domain and the Src‐Homology 2 (SH2) domain of pp60c‐src
  36. Purification of Bovine Thymus Cytosolic C-Terminal Src Kinase (CSK) and Demonstration of Differential Efficiencies of Phosphorylation and Inactivation of p56lyn and pp60c-src by CSK
  37. Autophosphorylation Induces Autoactivation and a Decrease in the Src Homology 2 Domain Accessibility of the Lyn Protein Kinase
  38. Characterization of Two Activated Mutants of Human pp60c-src That Escape c-Src Kinase Regulation by Distinct Mechanisms
  39. Synthesis and receptor binding activity of elephant β‐endorphin, a β‐endorphin homolog with highly potent analgesic activity#
  40. Chemical synthesis of human β‐endorphin(1–27) analogs by peptide segment coupling
  41. PRELIMINARY STUDY ON THE ANTINOCICEPTIVE EFFECT OF ELEPHANT β‐ENDORPHIN
  42. [16] Peptide inhibitors of CAMP-dependent protein kinase
  43. Circular dichroic investigations of secondary structure in synthetic peptide inhibitors for cAMP-dependent protein kinase: a model for inhibitory potential
  44. Identification of Functional Domains of the Inhibitor Protein of Camp-Dependent Protein Kinase
  45. Circular dichroic evidence for an ordered sequence of ligand/binding site interactions in the catalytic reaction of the cAMP-dependent protein kinase